Cooper J A, Bryan J, Schwab B, Frieden C, Loftus D J, Elson E L
J Cell Biol. 1987 Mar;104(3):491-501. doi: 10.1083/jcb.104.3.491.
Gelsolins are actin-binding proteins that cap, nucleate, and sever actin filaments. Microinjection of cytoplasmic or plasma gelsolin into living fibroblasts and macrophages did not affect the shape, actin distribution, deformability, or ruffling activity of the cells. Gelsolin requires calcium for activity, but the NH2-terminal half is active without calcium. Microinjection of this proteolytic fragment had marked effects: the cells rounded up, stopped ruffling, became soft, and stress fibers disappeared. These changes are similar to those seen with cytochalasin, which also caps barbed ends of actin filaments. Attempts to raise the cytoplasmic calcium concentration and thereby activate the injected gelsolin were unsuccessful, but the increases in calcium concentration were minimal or transient and may not have been sufficient. Our interpretation of these results is that at the low calcium concentrations normally found in cells, gelsolin does not express the activities observed in vitro at higher calcium concentrations. We presume that gelsolin may be active at certain times or places if the calcium concentration is elevated to a sufficient level, but we cannot exclude the existence of another molecule that inhibits gelsolin. Microinjection of a 1:1 gelsolin/actin complex had no effect on the cells. This complex is stable in the absence of calcium and has capping activity but no severing and less nucleation activity as compared with either gelsolin in calcium or the NH2-terminal fragment. The NH2-terminal fragment-actin complex also has capping and nucleating activity but no severing activity. On microinjection it had the same effects as the fragment alone. The basis for the difference between the two complexes is unknown. The native molecular weight of rabbit plasma gelsolin is 82,500, and the extinction coefficient at 280 nm is 1.68 cm2/mg. A new simple procedure for purification of plasma gelsolin is described.
凝溶胶蛋白是一种肌动蛋白结合蛋白,可封端、成核并切断肌动蛋白丝。将细胞质凝溶胶蛋白或血浆凝溶胶蛋白显微注射到活的成纤维细胞和巨噬细胞中,不会影响细胞的形状、肌动蛋白分布、变形能力或波动活性。凝溶胶蛋白的活性需要钙,但氨基末端的一半在没有钙的情况下也具有活性。显微注射这种蛋白水解片段会产生显著影响:细胞变圆,停止波动,变得柔软,应力纤维消失。这些变化与细胞松弛素引起的变化相似,细胞松弛素也会封端肌动蛋白丝的带刺末端。试图提高细胞质钙浓度从而激活注射的凝溶胶蛋白未成功,但钙浓度的增加很小或短暂,可能并不充分。我们对这些结果的解释是,在细胞中通常发现的低钙浓度下,凝溶胶蛋白不会表现出在较高钙浓度下体外观察到的活性。我们推测,如果钙浓度升高到足够水平,凝溶胶蛋白可能在某些时间或地点具有活性,但我们不能排除存在另一种抑制凝溶胶蛋白的分子。显微注射1:1的凝溶胶蛋白/肌动蛋白复合物对细胞没有影响。这种复合物在没有钙的情况下是稳定的,具有封端活性,但与钙存在时的凝溶胶蛋白或氨基末端片段相比,没有切断活性且成核活性较低。氨基末端片段 - 肌动蛋白复合物也具有封端和成核活性,但没有切断活性。显微注射时,它与单独的片段具有相同的效果。两种复合物之间差异的基础尚不清楚。兔血浆凝溶胶蛋白的天然分子量为82,500,在280 nm处的消光系数为1.68 cm2/mg。本文描述了一种纯化血浆凝溶胶蛋白的新的简单方法。